
Dissolution Testing – Drug Release Profiling
Overview:
Dissolution Testing is a critical analytical procedure used to determine the rate and extent to which an active pharmaceutical ingredient (API) dissolves from a solid dosage form (e.g., tablet or capsule) into a solution. This test provides essential insights into the bioavailability, performance, and consistency of pharmaceutical products.
Test Description:
The dosage form is placed in a dissolution vessel containing simulated gastric or intestinal fluid, and agitated using a USP Dissolution Apparatus (commonly Apparatus 1 – basket, or Apparatus 2 – paddle). The concentration of the drug in the fluid is measured at specific time intervals to assess how quickly and completely it dissolves.
Purpose & Benefits:
- Evaluate drug release profile and bioequivalence
- Support formulation development and quality control
- Ensure batch-to-batch consistency
- Aid in regulatory submissions and compliance
Industries Served:
- Pharmaceutical and Biotech Companies
- Contract Research & Manufacturing Organizations (CROs/CMOs)
- Generic Drug Manufacturers
- Academic and Regulatory Institutions
- Shelf-Life Testing – Stability & Expiry Determination
- Assay of Residual Solvents – Volatile Impurity Analysis
- Sterility Testing – Assurance of Microbial Purity
- Potency Testing – Verifying Therapeutic Efficacy
- Disintegration Testing – Ensuring Effective Drug Release
- Fungal and Bacterial Contamination Testing
- Heavy Metal Testing – Ensuring Product Safety & Regulatory Compliance
- pH Testing – Ensuring Product Stability, Safety, and Compliance
- Stability Testing of Biological Products
- Moisture Content Testing – Ensuring Stability, Efficacy, and Shelf-Life of Drug Products